Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-008827

Director acquired 6,562 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pacala Mark L Director 2023-03-17 Grant or award +6,562 88,399 D
Loading xslF345X04/wf-form4_167944596405529.xml…